Related Experiment Videos
Population pharmacokinetics of vancomycin in Chinese infants
Insights
This study developed a population pharmacokinetic (PPK) model for vancomycin in Chinese infants. The model, influenced by weight and postnatal age, supports individualized vancomycin dosing for better patient outcomes.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Clinical Pharmacy
Background:
- Vancomycin is crucial for treating serious bacterial infections in infants.
- Accurate dosing is challenging due to pharmacokinetic variability in pediatric populations.
- Optimizing vancomycin therapy requires understanding its behavior in specific infant groups.
Purpose of the Study:
- To establish a population pharmacokinetic (PPK) model for vancomycin in Chinese infants.
- To identify key patient factors influencing vancomycin pharmacokinetics.
- To provide a basis for individualized vancomycin dosing strategies.
Main Methods:
- Utilized 72 steady-state serum concentration datasets from 61 infants (0-1 year).
- Employed nonlinear mixed-effects modeling for population pharmacokinetic analysis.
- Assessed the impact of demographic and clinical variables on vancomycin clearance and volume of distribution.
Main Results:
- A one-compartment linear model with first-order elimination best described vancomycin pharmacokinetics.
- Patient weight and postnatal age significantly impacted vancomycin clearance.
- Population estimates for clearance and volume of distribution were 0.46 L/h and 4.45 L, respectively.
Conclusions:
- Successfully developed an initial vancomycin PPK model for Chinese infant patients.
- The model demonstrates good stability and predictive capability.
- This provides essential support for tailoring vancomycin therapy to individual infants.
Objective:
To determine the pharmacokinetics (PK) of vancomycin in Chinese infant patients using a population pharmacokinetic (PKK) approach in order to provide support for individualized vancomycin therapy.
Method:
The data included 72 sets of steady-state peak and trough serum concentrations from 61 infants (0 - 1 years). PPK analysis was performed using the nonlinear mixed-effects modeling software. Inter- and intraindividual variability was estimated for the clearance and distribution volume of vancomycin. The potential effects of patient sex, postnatal age, postconceptional age, height, weight, body surface area, body mass index, alanine aminotransferase, aspartate aminotransferase, total protein, albumin, white blood cell count, serum creatinine, and concomitant medications on vancomycin PKs were explored.
Results:
A one-compartment linear model with first-order elimination was used to describe the data. Weight and postnatal age had a significant influence on vancomycin clearance. The typical population parameter estimates of clearance and distribution volume were 0.46 L/h and 4.45 L, respectively. Goodness-of-fit plots and bootstrap outcomes confirmed the relatively good stability and prediction capability of the model.
Conclusion:
This study initially established a vancomycin PPK model to estimate individual PK parameters in Chinese infant patients. .